Dong Xie
Förmögenhet: 1 M $ per 2026-06-30
Förmögenhet: 1 M $ per 2026-06-30
Dong Xie formerly worked at China Vanke Co., Ltd., as Chairman-Supervisory Board from 2014 to 2025 and Shenzhen Hepalink Pharmaceutical Group Co., Ltd., as Independent Director from 2011 to 2017.
Dr. Xie received his Masters Business Admin degree in 1997 from Shanghai Jiao Tong University, doctorate degree in 2007 from Shanghai Jiao Tong University, and undergraduate degree in 1987 from Nanjing University of Science & Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-31 | 1 652 645 ( 0,02 % ) | 720 933 $ | 2026-06-30 | |
CHINA VANKE CO LTD DOM SH 18,13 % | 2025-12-31 | 1 239 484 ( 18,13 % ) | 540 700 $ | 2026-06-30 |
| Företag | Position | Slut |
|---|---|---|
| CHINA VANKE CO., LTD. | Ordförande | 2025-06-27 |
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Direktör/Styrelseledamot | 2017-05-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
China Vanke Co., Ltd.
China Vanke Co., Ltd. Real Estate DevelopmentFinance Develops and manages real estate properties | Finance |
Shanghai Jiao Tong University
Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University of Science & Technology
Nanjing University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån